70 related articles for article (PubMed ID: 15878321)
1. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W
Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321
[TBL] [Abstract][Full Text] [Related]
2. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.
Tatarczyńska E; Klodzińska A; Chojnacka-Wójcik E; Palucha A; Gasparini F; Kuhn R; Pilc A
Br J Pharmacol; 2001 Apr; 132(7):1423-30. PubMed ID: 11264235
[TBL] [Abstract][Full Text] [Related]
3. mGlu5 Receptor Blockade Within the Nucleus Accumbens Shell Reduces Behavioral Indices of Alcohol Withdrawal-Induced Anxiety in Mice.
Lee KM; Coelho MA; Class MA; Sern KR; Bocz MD; Szumlinski KK
Front Pharmacol; 2018; 9():1306. PubMed ID: 30483137
[TBL] [Abstract][Full Text] [Related]
4. Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile.
Carcache D; Vranesic I; Blanz J; Desrayaud S; Fendt M; Glatthar R
ACS Med Chem Lett; 2011 Jan; 2(1):58-62. PubMed ID: 24900255
[TBL] [Abstract][Full Text] [Related]
5. The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats.
Gokalp D; Unal G
Psychopharmacology (Berl); 2024 Jul; 241(7):1399-1415. PubMed ID: 38459971
[TBL] [Abstract][Full Text] [Related]
6. Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice.
Denning CJE; Madory LE; Herbert JN; Cabrera RA; Szumlinski KK
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339206
[TBL] [Abstract][Full Text] [Related]
7. Sex differences and hormonal regulation of metabotropic glutamate receptor synaptic plasticity.
Fabian CB; Seney ML; Joffe ME
Int Rev Neurobiol; 2023; 168():311-347. PubMed ID: 36868632
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological modulation of conditioned fear in the fear-potentiated startle test: a systematic review and meta-analysis of animal studies.
Groenink L; Verdouw PM; Zhao Y; Ter Heegde F; Wever KE; Bijlsma EY
Psychopharmacology (Berl); 2023 Nov; 240(11):2361-2401. PubMed ID: 36651922
[TBL] [Abstract][Full Text] [Related]
9. Control of Theta Oscillatory Activity Underlying Fear Expression by mGlu
Matulewicz P; Ramos-Prats A; Gómez-Santacana X; Llebaria A; Ferraguti F
Cells; 2022 Nov; 11(22):. PubMed ID: 36428984
[TBL] [Abstract][Full Text] [Related]
10. Genetic disruption of Grm5 causes complex alterations in motor activity, anxiety and social behaviors.
Xu J; Marshall JJ; Kraniotis S; Nomura T; Zhu Y; Contractor A
Behav Brain Res; 2021 Aug; 411():113378. PubMed ID: 34029630
[TBL] [Abstract][Full Text] [Related]
11. The infralimbic cortex and mGlu5 mediate the effects of chronic intermittent ethanol exposure on fear learning and memory.
Smiley CE; McGonigal JT; Valvano T; Newsom RJ; Otero N; Gass JT
Psychopharmacology (Berl); 2020 Nov; 237(11):3417-3433. PubMed ID: 32767063
[TBL] [Abstract][Full Text] [Related]
12. mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity.
Wu CS; Jew CP; Sun H; Ballester Rosado CJ; Lu HC
Psychopharmacology (Berl); 2020 Feb; 237(2):345-361. PubMed ID: 31646346
[TBL] [Abstract][Full Text] [Related]
13. Social Isolation During Adolescence Induces Anxiety Behaviors and Enhances Firing Activity in BLA Pyramidal Neurons via mGluR5 Upregulation.
Lin S; Li X; Chen YH; Gao F; Chen H; Hu NY; Huang L; Luo ZY; Liu JH; You QL; Yin YN; Li ZL; Li XW; Du ZJ; Yang JM; Gao TM
Mol Neurobiol; 2018 Jun; 55(6):5310-5320. PubMed ID: 28914419
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic effects of buspirone and MTEP in the Porsolt Forced Swim Test.
Lee KM; Coelho MA; Sern KR; Class MA; Bocz MD; Szumlinski KK
Chronic Stress (Thousand Oaks); 2017; 1():. PubMed ID: 28884167
[TBL] [Abstract][Full Text] [Related]
15. mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together?
Dravolina OA; Zvartau E; Danysz W; Bespalov AY
Psychopharmacology (Berl); 2017 May; 234(9-10):1333-1345. PubMed ID: 28285325
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and pharmacological validation of an integrated fear-potentiated startle and prepulse inhibition paradigm.
Zhang M; Li M
Behav Brain Res; 2016 Jul; 307():176-85. PubMed ID: 27059335
[TBL] [Abstract][Full Text] [Related]
17. N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.
Felts AS; Rodriguez AL; Morrison RD; Venable DF; Blobaum AL; Byers FW; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
Bioorg Med Chem Lett; 2016 Apr; 26(8):1894-900. PubMed ID: 26988308
[TBL] [Abstract][Full Text] [Related]
18. Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.
Bates BS; Rodriguez AL; Felts AS; Morrison RD; Venable DF; Blobaum AL; Byers FW; Lawson KP; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
Bioorg Med Chem Lett; 2014 Aug; 24(15):3307-14. PubMed ID: 24969015
[TBL] [Abstract][Full Text] [Related]
19. Decreased anxiety-like behavior and Gαq/11-dependent responses in the amygdala of mice lacking TRPC4 channels.
Riccio A; Li Y; Tsvetkov E; Gapon S; Yao GL; Smith KS; Engin E; Rudolph U; Bolshakov VY; Clapham DE
J Neurosci; 2014 Mar; 34(10):3653-67. PubMed ID: 24599464
[TBL] [Abstract][Full Text] [Related]
20. Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.
Felts AS; Rodriguez AL; Morrison RD; Venable DF; Manka JT; Bates BS; Blobaum AL; Byers FW; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
Bioorg Med Chem Lett; 2013 Nov; 23(21):5779-85. PubMed ID: 24074843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
